Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of …

Jun 12, 2023 · Former CEO and executive chairman of Merck, Ken Frazier, offers candid reflections on how crises tested his commitment to values—both Merck’s and his own.

Feb 4, 2021 · KENILWORTH, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief …

Kenneth C. Frazier is the Executive Chairman of Merck’s board of directors, a role he began in July 2021, following his retirement from a decade-long tenure as Merck’s President and Chief Executive …

Kenneth C. Frazier is the former Chairman and CEO of Merck, following his retirement from more than 30 years with the company, including a decade-long tenure as CEO.

Kenneth Carleton Frazier (born December 17, 1954) is an American business executive that served as the President and CEO of American multinational pharmaceutical company Merck & Co. from 2011 …

Kenneth C. Frazier is Executive Chairman of Merck’s board of directors, after stepping down as CEO on July 1, 2021. He previously served as President and Chief Executive Officer since 2011.

Aug 2, 2012 · Frazier has served in various capacities at Merck, including general counsel, secretary, and vice president. During his tenure as general counsel, Frazier achieved great success in leading …

Mar 21, 2014 · Kenneth C. Frazier is the first African American President of Merck & Co., a major pharmaceutical corporation. Frazier was elected by the Board of Directors to be the next CEO on …

Mar 7, 2025 · Ken Frazier, the former CEO of Merck, is a distinguished leader whose tenure was marked by integrity, innovation, and an unwavering commitment to social justice. Born in 1954, …